Skip to content
HomeLatest newsInnovationNod™: The digital coach designed to help your baby sleep better
Nod Mom-Baby video capture

Nod™: The digital coach designed to help your baby sleep better

Is your little one keeping you up at night? This new app could help answer some of your late-night “I need more sleep!” prayers.

It’s a question that has mystified new parents since the dawn of time: “How in the world do I get this child to go to sleep?”
Thanks to novel 21st-century technology—and a partnership between Johnson & Johnson Consumer Inc. and Rest Devices, Inc., makers of the Mimo™ Baby Monitor—the answer (and those much-needed Zzzzs) could now be far less elusive.

It’s a collaboration that marries technology and expert coaching from JOHNSON’S® BEDTIME® Baby Sleep App with analytics from Mimo™'s infant sleep wearables and crib monitors to produce a new app called Nod™.

The goal: Both companies have studied hundreds of thousands of baby sleep patterns, so by combining their expertise, the Nod™ app can provide parents with an advanced, personalized sleep coaching system—like having a baby sleep expert in your own home.

The app debuts at the Consumer Electronics Show in Las Vegas this week. In anticipation, we tapped Russel Walters, Research Fellow of Biophysics and Modeling at Johnson & Johnson; sleep expert Jodi Mindell, Ph.D., CBSM; and Dulcie Madden, Co-founder and CEO of Rest Devices, Inc., to walk us through the groundbreaking technology.

1775614113001-5270880003001-5270841823001-vs.jpg
nod_3_ƒ

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.